Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0002-9378(89)90485-7 | DOI Listing |
Indian Dermatol Online J
October 2024
MD Pathology, Consultant Pathologist, Vijaya Diagnostic Center, Visakhapatnam, Andhra Pradesh, India.
J Cosmet Dermatol
December 2024
School of Pharmacy, BRAC University, Dhaka, Bangladesh.
Background: There are exciting advances in the field of exosomes research as a potential regenerative therapy. Platelet-rich plasma represents an abundant source of exosomes.
Aim: To present evidence on the use of platelet-rich plasma-derived exosomes in dermatology and discuss current technical limitations.
Postepy Dermatol Alergol
October 2024
Department of Dermatology, Medical University of Silesia, Katowice, Poland.
Curr Oncol
September 2024
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
Docetaxel is a commonly used taxane chemotherapeutic agent in the treatment of a variety of cancers, including breast cancer, ovarian cancer, prostate cancer, non-small cell lung cancer, gastric cancer, and head and neck cancer. Docetaxel exerts its anti-cancer effects through inhibition of the cell cycle and induction of proapoptotic activity. However, docetaxel also impacts rapidly proliferating normal cells in the scalp hair follicles (HFs), rendering the HFs vulnerable to docetaxel-induced cell death and leading to chemotherapy-induced alopecia (CIA).
View Article and Find Full Text PDFPLoS One
August 2024
Department of Dermatology, Zhejiang Provincial Dermatology Hospital, Huzhou, Zhejiang, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!